Bluejay Diagnostics (BJDX) Financials: Revenue & Earnings
BJDX$0.55-0.02 -3.81%
$566,506
Market Cap
-0.05
P/E
0.00
Forward P/E
—
Score
Bluejay Diagnostics (BJDX) Financials: Revenue & Earnings
BJDX price $0.55 -0.02 -3.81%
- Ticker
- BJDX
- Price
- $0.55
- Change
- -0.02 -3.81%
- Market cap ?
- $566,506
- P/E ?
- -0.05
- Forward P/E ?
- 0.00
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Medical - Devices
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 249040 | 0 | 0 | 0 |
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony…
Earnings and financials
Bluejay Diagnostics, Inc. (BJDX) trades at $0.55, with a market cap of $566,506 and a trailing P/E of -0.05. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 249040 | 0 | 0 | 0 |
Insights · Dividends · Forecast · Financials · Learn